Exenatide once weekly combined with metformin reduced glycemic variability in type 2 diabetes by using flash glucose monitoring system

Table 4 Duration of hypoglycemia at baseline and after treatment [median (interquartile range)]

Variable	Before trial	After trial	P value
Hypoglycemia cutoff: 3.9 mmol/L
Throughout the day (min)	0 (0-2.3)	1.1 (0-22.0)	0.041
During day (min)	0 (0-1.3)	0 (0-3.0)	0.157
At night (min)	0 (0-0)	1.1 (0-10.0)	0.028
Hypoglycemia cutoff: 3.0 mmol/L
Throughout the day (min)	0 (0,0)	0 (0, 0)	0.207
During day (min)	0 (0,0)	0 (0, 0)	0.197
At night (min)	0 (0-0)	0 (0, 0)	0.465